about
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cellsAOPPs and the progression of kidney diseaseDecreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the ratAssociation of the CD14 gene -159C polymorphism with progression of IgA nephropathy.IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cellsDevelopment of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient miceLow Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexesMetabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy.Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case reportSignificance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables.Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese.Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway.Remission of Hematuria Improves Renal Survival in IgA Nephropathy.Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy.The Impact of Kidney Development on the Life Course: A Consensus Document for Action.
P2860
Q24680134-EFAD1C94-3A0A-4D5F-A676-32EFABD0EFA7Q26796619-2D795336-D5E1-40EB-AA85-A34F8A7DD379Q34336417-3E6864A8-BDDA-405A-AFA7-53BFAE7193A5Q35015952-8C3DAE00-D43B-41A7-BA5F-39B095F8A1C6Q35441532-306DAD56-152B-4636-A63C-009216936313Q35468711-FD82CCCA-60A4-473E-A573-E97F87783E1AQ35750178-6200BE46-6CCE-4E9B-9D1B-69442053AB4CQ35993496-FE26011C-5540-4444-89CA-10438DBCCD46Q36224280-B0566D61-66C1-4293-8F0F-BB007CF30104Q36295467-89B68314-975E-4F45-BB95-79A95DF17922Q36982068-2C97E162-9304-43E6-B5E3-4A0E2E467FD2Q37071587-0CC2A947-A367-4393-BAE0-5DC66285736EQ37157798-48856DEA-A243-4CA2-98C4-01254872A8EAQ37413387-DD204E0E-C56C-4347-BFCC-7DFAB3FFC2ECQ37449519-18253225-22DE-458D-A385-A8061C3ACB83Q37471445-AA52BD55-050C-4ED1-9D97-9A97AA8D09DDQ37572909-B504EB06-E09F-4E75-AC9E-6D872EE68310Q40168439-9B20CFBD-1046-49C5-A0C0-874D23B075FEQ47927162-D916837E-752D-4AE0-9584-62E54A49C8ADQ50921986-F920B4B8-A95A-4665-9108-D3258BC3B47AQ54016287-91B3F6D0-8FF8-4B22-BEB9-79F85162B146
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
IgA nephropathy: recent developments.
@ast
IgA nephropathy: recent developments.
@en
IgA nephropathy: recent developments.
@nl
type
label
IgA nephropathy: recent developments.
@ast
IgA nephropathy: recent developments.
@en
IgA nephropathy: recent developments.
@nl
prefLabel
IgA nephropathy: recent developments.
@ast
IgA nephropathy: recent developments.
@en
IgA nephropathy: recent developments.
@nl
P1476
IgA nephropathy: recent developments.
@en
P2093
P304
P577
2000-12-01T00:00:00Z